U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07786012) titled 'BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)' on Aug. 21.
Brief Summary: In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Cesarean Delivery
Intervention:
DRUG: buprenorphine
60 mcg buprenorphine intrathecal
DRUG: morphine
125mcg morphine intrathecal
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Icahn School of Medicine at Mount Sinai
Information provided by (Responsible Party): Daniel Katz, Icahn School of ...